← Leaderboards

Mary E McCaul

Johns Hopkins University

Google Scholar ↗PubMed ↗ORCID ↗

$21,975,059

Attributed

$30,015,571

Total exposure

18

Grants

13

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.5M · FY2005–25

$2.5M$1.9M$1.3M$625K$0

'05

'06

'07

'08

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$37,072,930 · 19

By mechanism

R01$20,285,239 · 9

P01$7,057,359 · 1

U01$3,593,055 · 1

U24$3,454,452 · 1

P50$2,128,612 · 1

R03$431,855 · 1

Top collaborators

Most similar at Johns Hopkins University

Same institution · by research overlap

Nicholas S Ialongo$26,586,427
George Bigelow$12,999,122
David D. Celentano$57,488,358
Eric C Strain$21,082,541
Dean Foster Wong$23,186,974

Others in their field

Top investigators on “Persons”

Wafaa M. El-Sadr · Columbia University Health Sciences$688,439,560
Lawrence Corey · Fred Hutchinson Cancer Center$646,462,796
Richard Marlink · Elizabeth Glaser Pediatric Aids Fdn$457,210,249
David R. Weir · University Of Michigan At Ann Arbor$386,183,647
Glenda E Gray · Wits Health Consortium (Pty), Ltd$377,922,183
Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$265,384,316

Research focus

PersonsAlcoholsAlcohol ConsumptionClinical ResearchAlcohol Use DisorderResponseEpidemiologyDrinkingRelapsePharmacotherapyPharmaceutical PreparationsDrug UsageReportingBaseAbstinenceMoodsScanningWomanCravingRecording Of Previous EventsCaringQuality Of LifeResourcesAlcohol Abuse Therapy

Grant awards (86)

Alcohol Research Consortium in HIV: Ending the HIV Epidemic through interventions and Epidemiology at the intersection of the alcohol and HIV care Continua$1,303,302

P01 · FY2025 · AA · contact PI

Alcohol Research Consortium in HIV: Ending the HIV Epidemic through interventions and Epidemiology at the intersection of the alcohol and HIV care Continua$1,355,870

P01 · FY2024 · AA · contact PI

Alcohol Research Consortium in HIV: Ending the HIV Epidemic through interventions and Epidemiology at the intersection of the alcohol and HIV care Continua$224,839

P01 · FY2024 · AA · contact PI

Alcohol Research Consortium in HIV: Ending the HIV Epidemic through interventions and Epidemiology at the intersection of the alcohol and HIV care Continua$1,360,895

P01 · FY2023 · AA · contact PI

Project 2-Optimization of Post-Transplant care via Biomarkers and Behavioral Interventions$406,763

P50 · FY2023 · AA · contact PI

Alcohol Research Consortium in HIV: Ending the HIV Epidemic through interventions and Epidemiology at the intersection of the alcohol and HIV care Continua$1,357,624

P01 · FY2022 · AA · contact PI

Combined mGluR5 PET and fMRI imaging of Sex Differences during Cocaine Withdrawal$685,732

R01 · FY2022 · DA · contact PI

Project 2-Optimization of Post-Transplant care via Biomarkers and Behavioral Interventions$421,935

P50 · FY2022 · AA · contact PI

Alcohol Research Consortium in HIV: Ending the HIV Epidemic through interventions and Epidemiology at the intersection of the alcohol and HIV care Continua$1,454,829

P01 · FY2021 · AA · contact PI

8/8: INIA Stress and Chronic Alcohol Interactions: Glucocorticoid antagonists in heavy drinkers:effects on fMRI connectivity, withdrawal and drinking$412,236

U01 · FY2021 · AA · contact PI

Project 2-Optimization of Post-Transplant care via Biomarkers and Behavioral Interventions$406,762

P50 · FY2021 · AA · contact PI

1/3 Alcohol Research Consortium in HIV - Administrative Core (ARCH-AC)$111,144

U24 · FY2021 · AA · contact PI

Combined mGluR5 PET and fMRI imaging of Sex Differences during Cocaine Withdrawal$693,042

R01 · FY2020 · DA · contact PI

Project 2-Optimization of Post-Transplant care via Biomarkers and Behavioral Interventions$486,389

P50 · FY2020 · AA · contact PI

8/8: INIA Stress and Chronic Alcohol Interactions: Glucocorticoid antagonists in heavy drinkers:effects on fMRI connectivity, withdrawal and drinking$412,236

U01 · FY2020 · AA

1/3 Alcohol Research Consortium in HIV - Administrative Core (ARCH-AC)$246,534

U24 · FY2020 · AA · contact PI

1/3 Alcohol Research Consortium in HIV - Administrative Core (ARCH-AC)$112,395

U24 · FY2020 · AA · contact PI

Combined mGluR5 PET and fMRI imaging of Sex Differences during Cocaine Withdrawal$707,627

R01 · FY2019 · DA · contact PI

Alcohol and Comorbid Tobacco Use Disorders: PET Imaging of Glutamate System Effects$677,271

R01 · FY2019 · AA · contact PI

8/8: INIA Stress and Chronic Alcohol Interactions: Glucocorticoid antagonists in heavy drinkers:effects on fMRI connectivity, withdrawal and drinking$412,236

U01 · FY2019 · AA

Project 2-Optimization of Post-Transplant care via Biomarkers and Behavioral Interventions$406,763

P50 · FY2019 · AA · contact PI

1/3 Alcohol Research Consortium in HIV - Administrative Core (ARCH-AC)$248,229

U24 · FY2019 · AA · contact PI

Alcohol and Comorbid Tobacco Use Disorders: PET Imaging of Glutamate System Effects$796,377

R01 · FY2018 · AA

Combined mGluR5 PET and fMRI imaging of Sex Differences during Cocaine Withdrawal$720,462

R01 · FY2018 · DA · contact PI

8/8: INIA Stress and Chronic Alcohol Interactions: Glucocorticoid antagonists in heavy drinkers:effects on fMRI connectivity, withdrawal and drinking$412,236

U01 · FY2018 · AA

1/3 Alcohol Research Consortium in HIV - Administrative Core (ARCH-AC)$257,069

U24 · FY2018 · AA · contact PI

Combined mGluR5 PET and fMRI imaging of Sex Differences during Cocaine Withdrawal$720,195

R01 · FY2017 · DA · contact PI

Alcohol and Comorbid Tobacco Use Disorders: PET Imaging of Glutamate System Effects$669,134

R01 · FY2017 · AA

8/8: INIA Stress and Chronic Alcohol Interactions: Glucocorticoid antagonists in heavy drinkers:effects on fMRI connectivity, withdrawal and drinking$412,236

U01 · FY2017 · AA

1/3 Alcohol Research Consortium in HIV - Administrative Core (ARCH-AC)$269,280

U24 · FY2017 · AA · contact PI

HOMOCYSTEINE, A CANDIDATE PERIPHERAL BIOMARKER FOR CEREBRAL mGluR5 ACTIVITY IN COMORBID ALCOHOL- AND TOBACCO USE DISORDER$108,553

R01 · FY2017 · AA

Alcohol and Comorbid Tobacco Use Disorders: PET Imaging of Glutamate System Effects$663,046

R01 · FY2016 · AA

Nicotine dependence, withdrawal and replacement therapy assessed by PET imaging$458,590

R01 · FY2016 · DA

Stress Effects on Alcohol Consumption: Age of onset and genes in heavy drinkers$313,519

U01 · FY2016 · AA

1/3 Alcohol Research Consortium in HIV - Administrative Core (ARCH-AC)$269,569

U24 · FY2016 · AA · contact PI

Alcohol and Comorbid Tobacco Use Disorders: PET Imaging of Glutamate System Effects$10,002

R01 · FY2016 · AA

Alcohol and Comorbid Tobacco Use Disorders: PET Imaging of Glutamate System Effects$547,292

R01 · FY2015 · AA

Nicotine dependence, withdrawal and replacement therapy assessed by PET imaging$456,005

R01 · FY2015 · DA

1/4 Alcohol Research Consortium in HIV-Administrative Core (ARCH-AC)$383,433

U24 · FY2015 · AA · contact PI

Stress Effects on Alcohol Consumption: Age of onset and genes in heavy drinkers$304,112

U01 · FY2015 · AA

Gender Effects on Amphetamine-Induced Dopamine Release and Subjective Responses$527,848

R01 · FY2014 · DA · contact PI

1/4 Alcohol Research Consortium in HIV-Administrative Core (ARCH-AC)$384,504

U24 · FY2014 · AA · contact PI

Stress Effects on Alcohol Consumption: Age of onset and genes in heavy drinkers$304,113

U01 · FY2014 · AA

Gender Effects on Amphetamine-Induced Dopamine Release and Subjective Responses$507,436

R01 · FY2013 · DA · contact PI

Ondansetron Pharmacotherapy for Hazardous Drinking, HIV+, African-American Women$464,372

R01 · FY2013 · AA · contact PI

Nicotine dependence, withdrawal and replacement therapy assessed by PET imaging$443,575

R01 · FY2013 · DA

1/4 Alcohol Research Consortium in HIV-Administrative Core (ARCH-AC)$369,661

U24 · FY2013 · AA · contact PI

Stress Effects on Alcohol Consumption: Age of onset and genes in heavy drinkers$291,572

U01 · FY2013 · AA

Ondansetron Pharmacotherapy for Hazardous Drinking, HIV+, African-American Women$508,479

R01 · FY2012 · AA · contact PI

Nicotine dependence, withdrawal and replacement therapy assessed by PET imaging$474,447

R01 · FY2012 · DA

1/4 Alcohol Research Consortium in HIV-Administrative Core (ARCH-AC)$398,579

U24 · FY2012 · AA · contact PI

Stress Effects on Alcohol Consumption: Age of onset and genes in heavy drinkers$318,559

U01 · FY2012 · AA

Nicotine dependence, withdrawal and replacement therapy assessed by PET imaging$534,859

R01 · FY2011 · DA

Gender Effects on Amphetamine-Induced Dopamine Release and Subjective Responses$533,283

R01 · FY2011 · DA · contact PI

Ondansetron Pharmacotherapy for Hazardous Drinking, HIV+, African-American Women$509,225

R01 · FY2011 · AA · contact PI

1/4 Alcohol Research Consortium in HIV-Administrative Core (ARCH-AC)$404,055

U24 · FY2011 · AA · contact PI

Gender Effects on Amphetamine-Induced Dopamine Release and Subjective Responses$530,118

R01 · FY2010 · DA · contact PI

Ondansetron Pharmacotherapy for Hazardous Drinking, HIV+, African-American Women$515,095

R01 · FY2010 · AA · contact PI

Imaging varenicline effects on nicotine & dopamine: Gene modulation$216,027

R03 · FY2010 · DA · contact PI

Gender Effects on Amphetamine-Induced Dopamine Release and Subjective Responses$516,020

R01 · FY2009 · DA · contact PI

Ondansetron Pharmacotherapy for Hazardous Drinking, HIV+, African-American Women$450,006

R01 · FY2009 · AA · contact PI

Imaging varenicline effects on nicotine & dopamine: Gene modulation$215,828

R03 · FY2009 · DA · contact PI

Brief Alcohol Intervention in HIV+ Women$353,805

R01 · FY2007 · AA · contact PI

BRIEF ALCOHOL INTERVENTION IN HIV+ WOMEN$19,652

M01 · FY2007 · RR · contact PI

OPIOID SYSTEM IN ALCOHOL DEPENDENCE$13,014

M01 · FY2007 · RR · contact PI

Dopamine: Alcohol Risk and Sensitivity$461,126

R01 · FY2006 · AA · contact PI

Brief Alcohol Intervention in HIV+ Women$354,981

R01 · FY2006 · AA · contact PI

OPIOD SYSTEM IN ALCOHOL DEPENDENCE$24,523

M01 · FY2006 · RR · contact PI

Dopamine: Alcohol Risk and Sensitivity$459,408

R01 · FY2005 · AA

Brief Alcohol Intervention in HIV+ Women$354,193

R01 · FY2005 · AA

Dopamine: Alcohol Risk and Sensitivity$446,968

R01 · FY2004 · AA

Brief Alcohol Intervention in HIV+ Women$345,129

R01 · FY2004 · AA

Dopamine: Alcohol Risk and Sensitivity$434,760

R01 · FY2003 · AA

Brief Alcohol Intervention in HIV+ Women$340,895

R01 · FY2003 · AA

PET IMAGING OF BRAIN OPIOID RECEPTORS IN ALCOHOLISM$498,631

R01 · FY2002 · AA

Dopamine: Alcohol Risk and Sensitivity$437,966

R01 · FY2002 · AA

NALTREXONE TREATMENT FOR ALCOHOLISM--PREDICTING OUTCOMES$363,626

R01 · FY2002 · AA

MARIJUANA INGESTION EFFECTS IN OFFSPRING OF ALCOHOLICS$0

M01 · FY2002 · RR

NALTREXONE TREATMENT FOR ALCOHOLISM--PREDICTING OUTCOMES$501,445

R01 · FY2001 · AA

MARIJUANA INGESTION EFFECTS IN OFFSPRING OF ALCOHOLICS$0

M01 · FY2001 · RR

NALTREXONE TREATMENT FOR ALCOHOLISM--PREDICTING OUTCOMES$504,215

R01 · FY2000 · AA

MARIJUANA INGESTION EFFECTS IN OFFSPRING OF ALCOHOLICS$65,169

M01 · FY2000 · RR

PHARMACOLOGICAL INFLUENCE ON ALCOHOL'S EFFECTS$0

M01 · FY2000 · RR

PHARMACOLOGICAL INFLUENCE ON ALCOHOL'S EFFECTS$0

M01 · FY2000 · RR

MARIJUANA INGESTION EFFECTS IN OFFSPRING OF ALCOHOLICS$0

M01 · FY2000 · RR

MARIJUANA INGESTION EFFECTS IN OFFSPRING OF ALCOHOLICS$0

M01 · FY2000 · RR